KROS Stock Summary and Trading Ideas (Keros Therapeutics | NASDAQ:KROS)

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

What symbol and exchange does Keros Therapeutics shares trade?

Keros Therapeutics trades on the NASDAQ stock market under the symbol KROS.

What is Keros Therapeutics stock price doing today?

As of September 22, 2026, KROS stock price climbed to $11.85 with 107,789 million shares trading.

What is Keros Therapeutics's Beta?

KROS has a beta of 1.46, meaning it tends to be more sensitive to market movements. KROS has a correlation of 0.11 to the broad based SPY ETF.

How much is Keros Therapeutics worth?

KROS has a market cap of $234.49 million. This is considered a Small Cap stock.

How much money does Keros Therapeutics make?

Last quarter Keros Therapeutics reported $0 in Revenue and -$1.45 earnings per share. This fell short of revenue expectation by $-635,000 and missed earnings estimates by -$.21.

What is the highest and lowest price Keros Therapeutics traded in the last 3 year period?

In the last 3 years, KROS traded as high as $73.00 and as low as $9.12.

What are the top ETFs holding Keros Therapeutics?

The top ETF exchange traded funds that KROS belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.

Is Keros Therapeutics (KROS) a good investment?

KROS has underperformed the market in the last year with a return of -23.8%, while SPY returned +17.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in KROS shares. However, KROS has outperformed the market in the last 3 month and 2 week periods, returning +11.3% and +4.7%, while SPY returned +4.0% and +0.8%, respectively. This indicates KROS has been having a stronger performance recently.

What are the support and resistance levels for Keros Therapeutics (KROS)?

KROS support price is $11.11 and resistance is $11.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KROS shares will trade within this expected range on the day.